Company: LIMN
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001410578-25-001746
Chunk: 3

Company: Liminatus Pharma, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 3
---
 | “Closing” means the closing of the Transactions. |

| ● | “Code” means the Internal Revenue Code of 1986, as amended and restated from time to time. |

| ● | “Common Stock” or “ParentCo Common Stock” means the common stock, par value $0.0001 per share, of the Company. |

| ● | “DGCL” means the General Corporation Law of the State of Delaware. |

| ● | “Effective Time” means the effective time of the Mergers. |

| ● | “Exchange Act” means the Securities Exchange Act of 1934, as amended. |

| ● | “Incentive Plan” means the Liminatus Pharma, Inc. 2025 Omnibus Equity Incentive Plan. |

| ● | “IPO” means Iris’s initial public offering, consummated on March 9, 2021, in which Iris sold 27,600,000 Iris Units at $10.00 per Iris Unit. |

| ● | “Iris Board” means the board of directors of Iris. |

| ● | “Iris Class A Common Stock” or “Iris Class A Shares” means the Class A common stock, par value $0.0001 per share, of Iris. |

2

| ● | “Iris Units” means the securities offered in Iris’s initial public offering, which consist of one share of Iris Class A Common Stock and one-quarter of one Public Warrant. |

| ● | “IRS” means the U.S. Internal Revenue Service. |

| ● | “Liminatus” means Liminatus Pharma, LLC, a Delaware limited liability company. |

| ● | “Liminatus assets” means Liminatus’s CD47 immune checkpoint inhibitor product candidates. |

| ● | “Liminatus Merger” means the merger of Liminatus Merger Sub with and into Liminatus with Liminatus being the surviving company in the merger and a wholly-owned subsidiary of ParentCo. |

| ● | “Liminatus Merger Sub” means Liminatus Pharma Merger Sub, Inc., a Delaware corporation. |

| ● | “Mergers” means, collectively, the SPAC Merger and the Liminatus Merger. |

| ● | “Merger Subs” means, collectively, the SPAC Merger Sub and the Liminatus Merger Sub. |

| ● | “Nasdaq” means The Nasdaq Stock